The FDA warned an asthma drug could induce despair. Many were never told.

The agency’s label, which was primarily aimed at doctors, was supposed to sound an alert about the 25-year-old medication, Singulair, also known by its generic name, montelukast. But it barely dented use.

Related Keywords

New York ,United States ,Reshma Ramachandran ,Sally Seymour ,Thomas Moore ,Anna Maria Rosenberg ,Johns Hopkins Center ,New York Times ,World Health Organization ,Yale University ,Facebook ,Get Breaking News ,Drug Safety , ,